PharmaSGP Holding SE/ DE000A2P4LJ5 /
| - - | Chg. - | Volume | Bid09:03:15 | Ask09:03:41 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 22.30EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 292.62 mill.EUR | 5.57% | 17.81 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.37 EUR | 37.00% |
| EPS Diluted: | - EUR | 37.00% |
| Revenues per Share: | 8.43 EUR | -99.88% |
| Book Value per Share: | 3.31 EUR | 27.92% |
| Cash Flow per Share: | 2.22 EUR | 7.86% |
| Dividend per Share: | 1.36 EUR | 177.55% |
| Total | in mill. | |
| Revenues: | 101.10 EUR | -99.88% |
| Net Income: | 16.40 EUR | 37.17% |
| Operating Cash Flow: | 26.64 EUR | - |
| Cash and Cash Equivalents: | 40.77 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 17.81 | 15.91 |
| P/S Ratio: | 2.89 | 2.59 |
| P/BV ratio: | 7.36 | 6.58 |
| P/CF Ratio: | 10.98 | 9.81 |
| PEG: | 0.48 | 0.43 |
| Earnings Yield: | 5.61% | 6.28% |
| Dividend Yield: | 5.57% | 6.24% |
| Market Capitalization | ||
| Market Capitalization: | 292.62 mill. EUR | 261.44 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 3.29 mill. EUR | 2.94 mill. EUR |
| Shares Outstanding: | 11.99 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 24.37% |
| Net Profit Margin: | 16.22% |
| Return on Equity: | 41.25% |
| Return on Assets: | 12.49% |
Financial Strength
| Liquidity I / Cash Ratio: | 165.76% |
| Liquidity II / Quick Ratio: | 203.12% |
| Liquidity III / Current Ratio: | 255.42% |
| Debt / Equity Ratio: | 230.28% |
| Dynam. Debt / Equity Ratio: | 343.65% |
Efficiency
| Employees: | 89 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 1,135,943.82 EUR |
| Net Income / Employee: | 184,235.96 EUR |
| Total Assets / Employee: | 1,475,269.66 EUR |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
